38 results on '"Ready, Joanna"'
Search Results
2. Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017
3. Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C–Infected Patients With Compensated and Decompensated Cirrhosis
4. Characteristics and Management of Patients with Chronic Hepatitis B in an Integrated Care Setting
5. Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population
6. Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long-term Treatment With Tumor Necrosis Factor Antagonists
7. No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients
8. Eight- or 12-Week Treatment of Hepatitis C with Ledipasvir/Sofosbuvir: Real-World Experience in a Large Integrated Health System
9. A predictive model for mortality within one year of liver transplantation at the time of wait-listing for transplant: a novel approach using machine learning algorithms in a large US multi-ethnic cohort
10. 531: DEVELOPMENT AND VALIDATION OF A RISK SCORE FOR PREDICTING HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B WITHIN A LARGE, REPRESENTATIVE, NORTHERN CALIFORNIA COHORT
11. EP1003: EVALUATION OF SOCIOECONOMIC STATUS WITHIN HOTSPOTS OF HEPATOCELLULAR CARCINOMA AMONG A LARGE DIVERSE PATIENT COHORT IN NORTHERN CALIFORNIA
12. Cancer in People with and without Hepatitis C Virus Infection: Comparison of Risk Before and After Introduction of Direct-Acting Antivirals
13. S1202 Demographics of Patients With Chronic Hepatitis B in an Integrated Care System
14. Reactivation of Hepatitis B (HBV) in Patients Treated with Anti-Tumor Necrosis Factor (anti-TNF) Agents: 72
15. 442 PREDICTING INDIVIDUALS WITH HEPATITIS C VIRUS CURE WHOSE RISK OF CIRRHOSIS, DECOMPENSATED CIRRHOSIS OR MORTALITY APPROACHES THE GENERAL POPULATION: IMPLICATIONS FOR WHO CAN SAFELY BE DISCHARGED FROM SPECIALTY CLINIC
16. 17 PREDICTING INDIVIDUALS WITH HEPATITIS C VIRUS CURE WHOSE RISK OF HEPATOCELLULAR CARCINOMA APPROACHES THE GENERAL POPULATION: IMPLICATIONS FOR WHO CAN SAFELY BE DISENROLLED FROM HEPATOCELLULAR CARCINOMA SURVEILLANCE PROTOCOLS
17. Mo1579 PREDICTING 30 DAY READMISSION FOLLOWING LIVER TRANSPLANTATION AT WAITLISTING IN PATIENTS WITHOUT HEPATOCELLULAR CARCINOMA: AN INNOVATIVE MACHINE LEARNING APPROACH
18. A Little Help from Our Friends: Intra-operative Endoscopy for the Extraction of an Ingested Foreign Body
19. Chronic Hepatitis B Management in a California Integrated Care Population: 311
20. Life Expectancy of Insured People With and Without Hepatitis C Virus Infection, 2007–2017
21. Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system
22. Serum Fibrosis Marker Panels FIB-4 Index and Aspartate Aminotransferase (AST)-to-Platelet Ratio Index (APRI) Are Equivalent to AST Alone at Predicting Liver Fibrosis in a Cohort of 1731 Patients Infected with Hepatitis C Virus
23. Racial/Ethnic and Socioeconomic Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus in an Insured Population
24. Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system.
25. Coexistence of primary biliary cirrhosis and sarcoidosis
26. Morbidity and Mortality of Portal Hypertension
27. 450 Simeprevir/Sofosbuvir Therapy in Hepatitis C (HCV) Infected Patients With Child-Pugh Class B/C Cirrhosis Compared to Matched Untreated and Protease Inhibitor (PI)-Triple Therapy Treated Control
28. A Little Help from Our Friends: Intra-operative Endoscopy for the Extraction of an Ingested Foreign Body
29. Practice Patterns and Treatment Outcomes in the Management of Chronic Hepatitis C (CHC) Infection in a Large Managed Care Cohort
30. Hemothorax after percutaneous liver biopsy: an unusual complication
31. Hepatitis C (HCV) patients have a higher cost of care and this is not fully explained by the high number of comorbid conditions
32. Effects of vasopressin on portal pressure during hemorrhage from esophageal varices
33. Assessment of the risk of bleeding from esophageal varices by continuous monitoring of portal pressure
34. Nitroglycerin for portal hypertension
35. The effects of ethanol administration on portal pressure and gastroesophageal collateral blood flow in patients with alcoholic cirrhosis
36. Image Diagnosis: Worm-Induced Biliary Obstruction.
37. 450 Simeprevir/Sofosbuvir Therapy in Hepatitis C (HCV) Infected Patients With Child-Pugh Class B/C Cirrhosis Compared to Matched Untreated and Protease Inhibitor (PI)-Triple Therapy Treated Control.
38. A Chronic Hepatitis B Identification and Surveillance Program Improves Care in an Integrated Health Plan.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.